DemetraKaramanos

Partner

New York + 1.212.326.3479

Demetra Karamanos represents public and private companies and private equity firms in significant domestic and cross-border transactions. Demetra's practice focuses on M&A, carve-out divestitures, leveraged buyouts, take privates, and special committee transactions. She also counsels public company boards on corporate governance, compliance, and fiduciary matters.

Demetra advises domestic and foreign clients in a broad range of industries, including consumer goods and retail, health care, pharmaceuticals, media and entertainment, energy, and telecommunications. She has worked on substantial matters for Procter & Gamble, Scotts Miracle-Gro, Bally's Corporation, Signature Aviation, and PHH Corporation. Prior to joining Jones Day, she advised Allergan, Anthem, Safeway, Odyssey Investment Partners, Books-A-Million, J.P. Morgan Securities, and Dish Network, among others, in a number of substantial transactions.

Demetra is an advisory board member of the Women's Initiative in Jones Day's New York Office and served as the partner co-chair of the 2020 Summer Associate Program and a coordinator of the 2018 Summer Associate Program. She is a board member of the Hellenic Lawyers Association.

Experience

  • Signature Aviation to sell Global Engine Services business to StandardAero for $230 millionJones Day is advising Signature Aviation plc, a market-leading provider of global aviation support services, in the $230 million sale of the Engine Repair and Overhaul (ERO) business to StandardAero, a portfolio company owned by The Carlyle Group and a leading provider of maintenance, repair, and overhaul services.
  • Detour Gold merges with Kirkland Lake Gold Ltd. for CA$4.9 billionJones Day advised Detour Gold Corporation in connection with its CA$4.9 billion stock merger with Kirkland Lake Gold Ltd.
  • Diamond S Shipping merges with tanker business of Capital Product Partners for $1.65 billionJones Day advised Diamond S Shipping L.P. in its $1.65 billion merger with the tanker business of Capital Product Partners (CPP).
  • Procter & Gamble acquires consumer health business of Merck KGaAJones Day advised The Procter & Gamble Company (“P&G”) in its €3.375 billion ($4.2 billion) acquisition of the worldwide consumer health business of Merck KGaA.
  • Twin River Worldwide Holdings acquires three casinos from Eldorado and Caesars for $180 millionJones Day advised Twin River Worldwide Holdings, Inc. in the $155 million acquisition of Eldorado Shreveport Resort and Casino in Shreveport, Louisiana, and the Mont Bleu Resort Casino & Spa in Lake Tahoe, Nevada, from Eldorado Resorts, Inc., and Bally's Atlantic City Hotel & Casino in New Jersey from Caesars Entertainment Corporation and Vici Properties Inc. for $25 million.
  • Twin River Worldwide Holdings combines with Dover Downs Gaming & Entertainment, Inc.Jones Day advised Twin River Worldwide Holdings, Inc. in its merger with Dover Downs Gaming & Entertainment, Inc.
  • EagleTree Capital acquires majority interest of Gaylord Chemical Company, LLCJones Day advised EagleTree Capital in its acquisition of a majority interest in and related financing of Gaylord Chemical Company, LLC, a specialty chemical producer.
  • Bombardier acquires Global 7500 aircraft wing program from Triumph Group Inc.Jones Day advised Bombardier Inc. in its acquisition of the wing manufacturing operations and assets relating to Triumph Group Inc.’s Global 7500 wing program.
  • Scotts Miracle-Gro acquires Sunlight Supply Inc. for $450 millionJones Day advised The Scotts Miracle-Gro Company and its wholly-owned subsidiary, Hawthorne Hydroponics LLC ("Hawthorne Gardening"), in connection with Hawthorne Gardening's purchase of the assets of Sunlight Supply, Inc. and various of its affiliates for $450 million.
  • Royalty Pharma acquires EMGALITY® royalty from Arteaus Therapeutics for $260 millionJones Day advised Royalty Pharma, the industry leader in acquiring pharmaceutical royalties, in its $260 million acquisition of the royalty interest held by Arteaus Therapeutics, LLC on future global net sales of Eli Lilly and Company’s EMGALITY® (galcanezumab), an anti-CGRP antibody for the prevention of migraine.
  • PHH Corporation sells remaining MSR portfolio for $912 million and enters subservicing agreement for 480,000 mortgage loans with New Residential Investment Corp.Jones Day advised PHH Corporation in its $912 million sale of all of its remaining MSR portfolio and related servicing advances to New Residential Investment Corp.
  • PGT Innovations acquires Western Window Systems for $360 millionJones Day advised PGT Innovations in its acquisition of Western Window Systems from PWP Growth Equity, the middle market private equity group of Perella Weinberg Partners, for $360 million in cash.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.